Although chronic macrolide therapy has demonstrated efficacy as a steroid-sparing agent in the treatment of COP, there are insufficient data to support a recommendation for use in COVID-19 secondary OP.
© Author s or their employer s 2021.
The mortality in the critically ill group of patients with COVID-19 is comparable with that of severe ARDS, reaching approximately 40% at day 30 after admission to the intensive care unit ICU.
B A colour-coded lung density map based on Hounsfield units at the same level as A.
Clinicians should consider the potential risks and benefits of corticosteroids and use CT as a guide on the different phases of CT patterns in patients with COVID-19.
Approximately 16 days after initiation of mechanical ventilation, lung compliance deteriorated, necessitating the use of higher driving pressure and respiratory rate and ultimately extracorporeal CO 2 removal to limit further ventilator-induced lung injury and to prevent the deleterious effects of respiratory acidosis on distant organs.